tissue

New Drug Reduces Breast Cancer Recurrence by 25%

Sep 20, 2020 PM EDT

Based on research findings, adding abemaciclib to hormonal therapy decreases the risk of recurrence of cancer by 25 percent in patients with HR+ or high-risk early hormone receptor-positive HER2- or human epidermal growth factor receptor 2 negative o..